Preethi Sundaram, Chief Strategy Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 36,428 shares at $14.49 ($528K) on 2022-09-15, disclosed to the SEC on 2022-09-16.
Open-market sale of $528k CPRX by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.49 | 18,214 | $264K | 50.0% |
| 2 | $14.49 | 18,214 | $264K | 50.0% |
| Total | $14.49 avg | 36,428 | $528K | 100% |
| Filing → |